Sarah Tabrizi
Professor Sarah Tabrizi is a prominent neurologist and the director of the University College London Huntington's Disease Centre. She has been instrumental in groundbreaking research on Huntington's disease, particularly in developing innovative gene therapies aimed at slowing the progression of this devastating condition. Recently, she celebrated a significant breakthrough in treatment that has shown to slow disease progression by 75%, offering hope to patients and families affected by Huntington's.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Spain | 1 | 8.00 | 0.09% | +0% | 46,754,778 | 42,698 | $1,400,000 | 1,279$ |
| Totals | 1 | 46,754,778 | 42,698 | $1,400,000 | 1,279$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Spain:
Sarah Tabrizi saw evidence that gene therapy can slow the progression of Huntington's disease.
8
Switzerland:
Sarah Tabrizi is the leader of the UK part of the study on Huntington's disease.
9
Iceland:
Sarah Tabrizi led the research work on treating Huntington's disease.
9
United Kingdom:
Prof Sarah Tabrizi led the UK part of the trial and described the results as 'spectacular'.
9